Company Filing History:
Years Active: 2024-2025
Title: Michael D Kaplan: Innovator in Therapeutic Antibodies
Introduction
Michael D Kaplan is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of therapeutic antibodies, holding a total of four patents. His work focuses on innovative solutions for treating diseases, particularly cancer.
Latest Patents
Among his latest patents is the development of DLL3 single domain antibodies and therapeutic compositions thereof. This invention provides binding polypeptides that specifically target DLL3, including fusion proteins and chimeric antigen receptors. Additionally, he has created pharmaceutical compositions that incorporate these polypeptides, along with methods for their use in treating various diseases and conditions. Another notable patent involves multispecific polypeptide constructs with constrained CD3 binding. This invention outlines the creation of multispecific polypeptides connected by non-cleavable linkers, along with methods for their therapeutic, diagnostic, and prophylactic applications.
Career Highlights
Michael has worked with notable companies such as Inhibrx Biosciences, Inc. and Inhibrx, Inc. His career reflects a commitment to advancing medical science through innovative research and development.
Collaborations
Throughout his career, Michael has collaborated with talented individuals, including Brendan P Eckelman and Katelyn M Willis. These partnerships have contributed to the success of his projects and the advancement of therapeutic technologies.
Conclusion
Michael D Kaplan is a distinguished inventor whose work in therapeutic antibodies has the potential to transform cancer treatment. His innovative patents and collaborations highlight his significant impact on the field of medical research.